Dr. Joe Germino
We’re excited to welcome Dr. Joseph Germino to The Life Raft Group’s Board!
Dr. Germino is a retired medical oncologist who most recently served as the VP of Medical Affairs at Bayer, the pharmaceutical company behind Stivarga (regorafenib), a third-line treatment for GIST.
Before his time at Bayer, he treated patients with sarcoma and melanoma at the Cancer Institute of New Jersey. With experience in both patient care and the pharmaceutical industry, Dr. Germino brings a well-rounded perspective on healthcare from multiple angles.
“My first experience with the LRG was about ten years ago when we were working to get regorafenib approved. We connected with the team at LRG, and I was immediately impressed. Unlike most advocacy groups I’d worked with, LRG was incredibly sophisticated—analyzing patient data, collaborating with a science team, publishing a newsletter, and advocating effectively. It was a strong partnership, and they stood out as a truly impactful organization.“ shared Dr. Germino.
We’re honored to have him on our board, bringing his expertise in drug development and his deep understanding of the challenges patients face. His insights will be invaluable as we continue to amplify the patient voice and make a lasting impact. We’re looking forward to the fresh perspective and passion he’ll bring to our advocacy efforts!
